Clinical Trials List
Protocol NumberPL3397-A-U126
Completed
2017-08-01 - 2018-12-31
Others
Terminated1
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3-5 participants
-
Global
30 participants
